FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ferdinand Wit

Research Profile

Disorders

HIV Infections

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Marlous L Grijsen; Paul Lips; Maria Prins; Peter Reiss; Ineke G Stolte; Saskia M E Vrouenraets; Ferdinand W N M Wit; Jan M Prins
Low bone mineral density, regardless of HIV status, in men who have sex with men.
Marlous L Grijsen; Rebecca Holman; Selwyn H Lowe; Kees Brinkman; Frank de Wolf; Luuk Gras; Ferdinand W N M Wit; Jan M Prins
Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.
Saskia M E Vrouenraets; Ferdinand W N M Wit; Peter Reiss; Kees Brinkman; Hansjakob Furrer; Christoph A Fux; Evian Fernandez Garcia; Frans J Hoek; Ray T Krediet; Jan P van Straalen
A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ferdinand Wit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marlous L Grijsen; Paul Lips; Maria Prins; Peter Reiss; Ineke G Stolte; Saskia M E Vrouenraets; Ferdinand W N M Wit; Jan M Prins
Low bone mineral density, regardless of HIV status, in men who have sex with men.
The Journal of infectious diseases 2013;207(3):386-91.
2012: Marlous L Grijsen; Rebecca Holman; Selwyn H Lowe; Kees Brinkman; Frank de Wolf; Luuk Gras; Ferdinand W N M Wit; Jan M Prins
Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.
AIDS (London, England) 2012;26(15):1974-7.
2012: Saskia M E Vrouenraets; Ferdinand W N M Wit; Peter Reiss; Kees Brinkman; Hansjakob Furrer; Christoph A Fux; Evian Fernandez Garcia; Frans J Hoek; Ray T Krediet; Jan P van Straalen
A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function.
Clinical nephrology 2012;77(4):311-20.
2012: Marlous L Grijsen; Andy I M Hoepelman; Rebecca Holman; Jan M Prins; Guido E van den Berk; Ferdinand W N M Wit; Frank de Wolf; Luuk Gras
No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia.
Antiviral therapy 2012;17(8):1609-13.
2012: Marleen E Hendriks; Wendy Janssens; Amos M Kahwa; Berber Kramer; Judith Lammers; Joep M A Lange; Sayoki G Mfinanga; Tobias F Rinke de Wit; Marijke T L Roos; Tanimola M Akande; Igna Bonfrer; Lizzy M Brewster; Ingrid H de Beer; Esegiel Gaeb; Peter Gatongi; Jacques van der Gaag; Gert Van Rooy; Ferdinand W N M Wit; Constance Schultsz
Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.
PloS one 2012;7(3):e32638.
2011: Saskia M E Vrouenraets; Ferdinand W N M Wit; Nico G G M Abeling; Kees Brinkman; Hansjakob Furrer; Christoph A Fux; Evian Fernandez Garcia; Frans J Hoek; Ray T Krediet; Peter Reiss
Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
AIDS (London, England) 2011;25(17):2149-55.
2011: Saskia M E Vrouenraets; Ferdinand W N M Wit; Clotilde Allavena; E Dejesus; E Fernandez Garcia; M Fisher; W D Hardy; A G Jackson; Dushyantha Jayaweera; Christine Katlama; S Mauss; G J Moyle; Francois Raffi; Peter Reiss; L Slama; A van Eeden
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.
HIV medicine 2011;12(10):620-31.
2011: Luuk Gras; Ard I van Sighem; Daniela Bezemer; Colette Smit; Ferdinand W N M Wit; Frank de Wolf
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test.
AIDS (London, England) 2011;25(6):813-8.
2009: Jasper van der Lugt; Meena Gorowara; Anchalee Avihingsanon; David Burger; Jintanat Ananworanich; Kancharat Sringam; Stephen Kerr; Ferdinand W N M Wit; Joep Lange; Kiat Ruxrungtham
Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.
AIDS (London, England) 2009;23(9):1176-9.
2008: Jasper van der Lugt; Reshma Saskia Autar; Sasiwimol Ubolyam; Evian Fernandez Garcia; Jongkol sankote; Anchalee Avihingsanon; Anchalee Avihingson; Theshinee Chuenyam; David A Cooper; Joep Lange; Praphan Phanuphak; Ferdinand W N M Wit; Kiat Ruxrungtham; David Burger
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.
The Journal of antimicrobial chemotherapy 2008;61(5):1145-53.
2008: Jeannine F J B Nellen; M Damming; M H Godfried; Kees Boer; M E van der Ende; David Burger; Frank de Wolf; Ferdinand W N M Wit; Jan M Prins
Steady-state nevirapine plasma concentrations are influenced by pregnancy.
HIV medicine 2008;9(4):234-8.
2008: Ferdinand W N M Wit; Anouk M Kesselring; Luuk Gras; Clemens Richter; Marchina E Van Der Ende; Kees Brinkman; Joep M A Lange; Frank de Wolf; Peter Reiss
Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(6):933-40.
2008: Elisabeth van Leeuwen; Ferdinand W N M Wit; Sjoerd Repping; Jan Karel M Eeftinck Schattenkerk; Peter Reiss; Fulco van der Veen; Jan M Prins
Effects of antiretroviral therapy on semen quality.
AIDS (London, England) 2008;22(5):637-42.
2007: Miriam Casula; Nienke Vrisekoop; Ferdinand W N M Wit; Michel P De Baar; Anthony de Ronde; Frank Miedema; Peter Reiss
Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.
The Journal of infectious diseases 2007;196(3):371-6.
2007: Reshma Saskia Autar; Ferdinand W N M Wit; Jongkol sankote; Duanghathai Sutthichom; Elly Kimenai; Elly A M Hassink; Andrew Hill; David A Cooper; Praphan Phanuphak; Joep M A Lange; David Burger; Kiat Ruxrungtham
Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
AIDS (London, England) 2007;21(12):1535-9.
2007: Raaj R Sankatsing; Ferdinand W N M Wit; Nadine Pakker; Joseph Vyankandondera; Francis Mmiro; Pius Okong; John J Kastelein; Joep M A Lange; Erik S G Stroes; Peter Reiss
Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudy.
The Journal of infectious diseases 2007;196(1):15-22.
2007: Saskia M E Vrouenraets; Ferdinand W N M Wit; Jacqueline van Tongeren; Joep M A Lange
Efavirenz: a review.
Expert opinion on pharmacotherapy 2007;8(6):851-71.
2007: Papa Salif Sow; Leander F Otieno; Emmanuel Bissagnene; Cissy Kityo; Ruurd Bennink; Philippe Clevenbergh; Ferdinand W N M Wit; Esther Waalberg; Tobias F Rinke de Wit; Joep M A Lange
Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
Journal of acquired immune deficiency syndromes (1999) 2007;44(3):262-7.
2007: Reshma Saskia Autar; Mark A Boyd; Ferdinand W N M Wit; Kiat Ruxrungthams; Jongkol sankote; Joep Lange; David A Cooper; Praphan Phanuphak; David Burger; Peter Reiss
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen.
Antiviral therapy 2007;12(8):1265-71.
2007: Joost N Vermeulen; Dirk K F Meijer; Jan Over; Joep Lange; Johannes H Proost; Hester I Bakker; Leonie Beljaars; Ferdinand W N M Wit; Jan M Prins
A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor.
Antiviral therapy 2007;12(2):273-8.
2007: Frank van Leth; Ferdinand W N M Wit; Joep M A Lange
Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance: response.
BMC medical research methodology 2007;7():14.
2007: Miriam Casula; Marc van der Valk; Ferdinand W N M Wit; M A Nievaard; Peter Reiss
Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition.
HIV medicine 2007;8(1):32-7.
2006: Sanneke Koekkoek; Laura Eggermont; Leo De Sonneville; Thidarat Jupimai; Saijai Wicharuk; Wichitea Apateerapong; Theshinee Chuenyam; Joep Lange; Ferdinand W N M Wit; Chitsanu Pancharoen; Praphan Phanuphak; Jintanat Ananworanich
Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease.
Journal of neurology 2006;253(12):1615-24.
2006: F Van Leth; Bregt S Kappelhoff; D Johnson; Marcelo H Losso; Anna Boron-Kaczmarska; M S Saag; J-M Livrozet; David B Hall; J Leith; Alwin D R Huitema; Ferdinand W N M Wit; Jos H Beijnen; Joep M A Lange
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.
AIDS research and human retroviruses 2006;22(3):232-9.
2005: Miriam Casula; Gerrit Jan Weverling; Ferdinand W N M Wit; Eveline C Timmermans; Michael Stek; Joep M A Lange; Peter Reiss
Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
The Journal of infectious diseases 2005;192(10):1794-800.
2005: K Pogány; Hans L Zaaijer; Jan M Prins; Ferdinand W N M Wit; Joep M A Lange; Marcel G H M Beld
Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
AIDS research and human retroviruses 2005;21(11):922-6.
2005: Reshma Saskia Autar; Marta Boffito; Elly A M Hassink; Ferdinand W N M Wit; Jintanat Ananworanich; Umaporn Siangphoe; Anton Pozniak; David A Cooper; Praphan Phanuphak; Joep M A Lange; Kiat Ruxrungtham; David Burger
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
The Journal of antimicrobial chemotherapy 2005;56(5):908-13.
2005: Frank van Leth; Casper B Huisamen; Roberto Badaro; Bernard Vandercam; Joss de Wet; Julio S G Montaner; David B Hall; Ferdinand W N M Wit; Joep M A Lange
Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):296-300.
2005: Ferdinand W N M Wit; Daniel H Blanckenberg; Kees Brinkman; Jan M Prins; Marchina E Van Der Ende; M M E Schneider; Jan W Mulder; Frank de Wolf; Joep Ma Lange
Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.
AIDS (London, England) 2005;19(3):345-8.
2005: Reshma Saskia Autar; Ferdinand W N M Wit; Jongkol sankote; Apicha Mahanontharit; Thanomsak Anekthananon; Piroon Mootsikapun; Khanjtta Sujaikaew; David A Cooper; Joep M A Lange; Praphan Phanuphak; Kiat Ruxrungtham; David Burger
Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis.
Antiviral therapy 2005;10(8):937-43.
2004: Frank van Leth; Brian Conway; Hector Laplumé; Des Martin; Martin Fisher; Ante Jelaska; Ferdinand W N M Wit; Joep M A Lange
Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenz.
Antiviral therapy 2004;9(5):721-8.
2004: Jeannine F J B Nellen; Igor Schillevoort; Ferdinand W N M Wit; Alina S Bergshoeff; Mieke H Godfried; Kees Boer; Joep M A Lange; David Burger; Jan M Prins
Nelfinavir plasma concentrations are low during pregnancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(5):736-40.
2004: Monique M R de Maat; Jeannine F J B Nellen; Alwin D R Huitema; Ferdinand W N M Wit; Jan W Mulder; Jan M Prins; Jos H Beijnen
Race is not associated with nevirapine pharmacokinetics.
Therapeutic drug monitoring 2004;26(4):456-8.
2004: Jeannine F J B Nellen; Ferdinand W N M Wit; Frank de Wolf; Suzanne Jurriaans; Joep M A Lange; Jan M Prins
Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.
Journal of acquired immune deficiency syndromes (1999) 2004;36(4):943-50.
2004: Frank van Leth; Praphan Phanuphak; Kiat Ruxrungtham; Ezio Baraldi; S Miller; B Gazzard; Pedro Cahn; U G Lalloo; I P van der Westhuizen; D R Malan; M A Johnson; B R Santos; F Mulcahy; Robin Wood; G C Levi; G Reboredo; Kathleen E Squires; Isabel Cassetti; D Petit; F Raffi; Christine Katlama; Robert L Murphy; Andrzej Horban; J P Dam; Elly A M Hassink; Remko van Leeuwen; P Robinson; Ferdinand W N M Wit; Joep M A Lange
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.
Lancet 2004;363(9417):1253-63.
2004: Frank van Leth; Ferdinand W N M Wit; Peter Reiss; J K M E Schattenkerk; Marchina E Van Der Ende; M M E Schneider; Jan W Mulder; P H J Frissen; Frank de Wolf; Joep M A Lange
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy.
HIV medicine 2004;5(2):74-81.
2002: Ferdinand W N M Wit; Ronald P van Rij; Gerrit Jan Weverling; Joep M A Lange; Hanneke Schuitemaker
CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.
The Journal of infectious diseases 2002;186(12):1726-32.
2002: Ole Kirk; Peter Reiss; Caterina Uberti-Foppa; Markus Bickel; Jan Gerstoft; Christian Pradier; Ferdinand W N M Wit; bruno ledergerber; Jens D Lundgren; Hansjakob Furrer
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Annals of internal medicine 2002;137(4):239-50.
2002: Ferdinand W N M Wit; Gerrit Jan Weverling; Jan F L Weel; Suzanne Jurriaans; Joep M A Lange
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.
The Journal of infectious diseases 2002;186(1):23-31.
2002: Mette D Hazenberg; Sigrid A Otto; Ferdinand W N M Wit; Joep M A Lange; Dörte Hamann; Frank Miedema
Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.
AIDS (London, England) 2002;16(9):1287-9.
2002: Jeanne P Dieleman; Miriam C J M Sturkenboom; Ferdinand W N M Wit; Marielle Jambroes; Jan W Mulder; Jacob H Ten Veen; Job Juttmann; Bruno H Ch Stricker; Joep M A Lange; Marchina E Van Der Ende
Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.
The Journal of infectious diseases 2002;185(9):1261-8.
2002: Rieneke van Praag; Ferdinand W N M Wit; Suzanne Jurriaans; Frank de Wolf; Jan M Prins; Joep M A Lange
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.
AIDS (London, England) 2002;16(5):719-25.
2001: Ferdinand W N M Wit; Robin Wood; Andrzej Horban; Marek Beniowski; Reinhold E Schmidt; Glenda Gray; Adriano Lazzarin; A Lafeuillade; D Paes; Hilde Carlier; L van Weert; C de Vries; Remko van Leeuwen; Joep M A Lange
Prednisolone does not prevent hypersensitivity reactions in antiretroviral drug regimens containing abacavir with or without nevirapine.
AIDS (London, England) 2001;15(18):2423-9.
2001: Marc van der Valk; EH Gisolf; Peter Reiss; Ferdinand W N M Wit; A Japour; Gerrit Jan Weverling; Sven A Danner
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.
AIDS (London, England) 2001;15(7):847-55.
2001: MH Reijers; Gerrit Jan Weverling; Suzanne Jurriaans; Marijke Th L Roos; Ferdinand W N M Wit; Hugo M Weigel; Reinier W Ten Kate; Jan W Mulder; Clemens Richter; Hadewych J M ter Hofstede; Herman Sprenger; Richard Hoetelmans; Hanneke Schuitemaker; Joep M A Lange
The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.
AIDS (London, England) 2001;15(1):129-31.
2000: M den Brinker; Ferdinand W N M Wit; Pauline M E Wertheim-van Dillen; Suzanne Jurriaans; Jan F L Weel; Remko van Leeuwen; Nadine Pakker; Peter Reiss; Sven A Danner; Gerrit Jan Weverling; Joep M A Lange
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection.
AIDS (London, England) 2000;14(18):2895-902.
2000: Ferdinand W N M Wit
Experience with nevirapine in previously treated HIV-1-infected individuals.
Antiviral therapy 2000;5(4):257-66.
2000: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Ferdinand W N M Wit; Peter Reiss; Joep M A Lange; MO Kwakkelstein; Jos H Beijnen; Richard Hoetelmans
Nevirapine plus didanosine: once or twice daily combination?
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):93-5.
2000: DR Clark; S Repping; Nadine Pakker; J M Prins; Daan W Notermans; Ferdinand W N M Wit; Peter Reiss; S A Danner; R A Coutinho; Joep M A Lange; Frank Miedema
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy.
Blood 2000;96(1):242-9.
2000: Rolf P G van Heeswijk; Agnes I Veldkamp; Jan W Mulder; Pieter L Meenhorst; Ferdinand W N M Wit; Joep M A Lange; Sven A Danner; NA Foudraine; MO Kwakkelstein; Peter Reiss; Jos H Beijnen; Richard Hoetelmans
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
AIDS (London, England) 2000;14(8):F77-82.
1999: Ferdinand W N M Wit; Remko van Leeuwen; Gerrit Jan Weverling; Suzanne Jurriaans; K Nauta; Radjin Steingrover; J Schuijtemaker; X Eyssen; D Fortuin; M Weeda; Frank de Wolf; Peter Reiss; Sven A Danner; Joep M A Lange
Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons.
The Journal of infectious diseases 1999;179(4):790-8.
1999: Nadine Pakker; E D Kroon; Marijke Th L Roos; Sigrid A Otto; D Hall; Ferdinand W N M Wit; Dörte Hamann; Marchina E Van Der Ende; Frans A Claessen; Robbert H Kauffmann; Peter P Koopmans; Frank P Kroon; C H ten Napel; Herman Sprenger; Hugo M Weigel; Julio S G Montaner; Joep M A Lange; Peter Reiss; P T A Schellekens; Frank Miedema
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group.
AIDS (London, England) 1999;13(2):203-12.
1998: MH Reijers; Gerrit Jan Weverling; Suzanne Jurriaans; Ferdinand W N M Wit; R van Leeuwen; Sylvia M Bruisten; P H J Frissen; Hugo M Weigel; Jan W Mulder; Reinier W Ten Kate; Frank de Wolf; Hanneke Schuitemaker; Joep M A Lange
[Amsterdam duration of antiretroviral medication (ADAM)--study: induction-suppression treatment in HIV-I infection, preliminary results].
Nederlands tijdschrift voor geneeskunde 1998;142(40):2230.
1998: Richard Hoetelmans; MH Reijers; Gerrit Jan Weverling; Reinier W Ten Kate; Ferdinand W N M Wit; Jan W Mulder; Hugo M Weigel; P H J Frissen; M Roos; Suzanne Jurriaans; Hanneke Schuitemaker; Frank de Wolf; Jos H Beijnen; Joep M A Lange
The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.
AIDS (London, England) 1998;12(11):F111-5.
1998: MH Reijers; Gerrit Jan Weverling; S Jurriaans; Ferdinand W N M Wit; Hugo M Weigel; Reinier W Ten Kate; Jan W Mulder; P H J Frissen; R van Leeuwen; P Reiss; H Schuitemaker; Frank de Wolf; Joep M A Lange
Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.
Lancet 1998;352(9123):185-90.
1998: Ferdinand W N M Wit; Cees Sol; Neil Renwick; Marijke Th L Roos; S T Pals; R van Leeuwen; Jaap Goudsmit; Peter Reiss
Regression of AIDS-related Kaposi's sarcoma associated with clearance of human herpesvirus-8 from peripheral blood mononuclear cells following initiation of antiretroviral therapy.
AIDS (London, England) 1998;12(2):218-9.